Chemoimmunotherapy for high-risk neuroblastoma

被引:2
|
作者
Kushner, Brian H. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10065 USA
来源
LANCET ONCOLOGY | 2017年 / 18卷 / 07期
关键词
COLONY-STIMULATING FACTOR;
D O I
10.1016/S1470-2045(17)30337-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:845 / 846
页数:3
相关论文
共 50 条
  • [1] TREATMENT OF HIGH-RISK NEUROBLASTOMA USING DINUTUXIMAB CHEMOIMMUNOTHERAPY IN ALL CYCLES OF INDUCTION
    Cupit-Link, Margaret
    Federico, Sara
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S4 - S5
  • [2] Naxitamab-Based Chemoimmunotherapy for Resistant High-Risk Neuroblastoma: Preliminary Results of Hits Treatment
    Mora, J.
    Castaneda, A.
    Flores, M.
    Gorostegui, M.
    Simao, M.
    Santa-Maria, V.
    Garraus, M.
    Chamizo, A.
    Lazaro, J. J.
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S32 - S32
  • [3] Treatment of High-Risk Neuroblastoma
    Hizhnikov, A.
    Kazancev, A.
    Kerimov, P.
    Pimenov, R.
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S447 - S447
  • [4] Treatment of High-Risk Neuroblastoma
    Sung, Kiwoong
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S3 - S3
  • [5] Treatment of High-Risk Neuroblastoma
    Krystal, Julie
    Foster, Jennifer H.
    CHILDREN-BASEL, 2023, 10 (08):
  • [6] Induction for high-risk neuroblastoma
    Kushner, Brian H.
    Cheung, Nai-Kong V.
    PEDIATRIC BLOOD & CANCER, 2007, 49 (03) : 221 - 223
  • [7] Naxitamab-based chemoimmunotherapy for resistant high-risk neuroblastoma: Results of "HITS" phase II study.
    Modak, Shakeel
    Kushner, Brian H.
    Mauguen, Audrey
    Castaneda, Alicia
    Varo, Amalia
    Gorostegui, Maite
    Munoz, Juan Pablo
    Santa-Maria, Vicente
    Basu, Ellen M.
    Cardenas, Fiorella Iglesias
    Pandit-Taskar, Neeta
    Cheung, Nai-Kong V.
    Mora, Jaume
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [8] Dinutuximab: A Review in High-Risk Neuroblastoma
    Sheridan M. Hoy
    Targeted Oncology, 2016, 11 : 247 - 253
  • [9] Retinoid therapy of high-risk neuroblastoma
    Reynolds, CP
    Matthay, KK
    Villablanca, JG
    Maurer, BJ
    CANCER LETTERS, 2003, 197 (1-2) : 185 - 192
  • [10] Influence of Sarcopenia in High-risk Neuroblastoma
    Kawakubo, Naonori
    Souzaki, Ryota
    Koga, Yuuki
    Kinoshita, Yoshiaki
    Ohga, Shouichi
    Taguchi, Tomoaki
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S43 - S43